AU754212B2 - Epothilone derivatives, a method for the production thereof, and their use - Google Patents

Epothilone derivatives, a method for the production thereof, and their use Download PDF

Info

Publication number
AU754212B2
AU754212B2 AU43611/99A AU4361199A AU754212B2 AU 754212 B2 AU754212 B2 AU 754212B2 AU 43611/99 A AU43611/99 A AU 43611/99A AU 4361199 A AU4361199 A AU 4361199A AU 754212 B2 AU754212 B2 AU 754212B2
Authority
AU
Australia
Prior art keywords
formula
compound
group
atom
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43611/99A
Other languages
English (en)
Other versions
AU4361199A (en
Inventor
Gerhard Hoefle
Thomas Leibold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Original Assignee
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum fuer Infektionsforschung HZI GmbH filed Critical Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Publication of AU4361199A publication Critical patent/AU4361199A/en
Application granted granted Critical
Publication of AU754212B2 publication Critical patent/AU754212B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU43611/99A 1998-05-08 1999-05-07 Epothilone derivatives, a method for the production thereof, and their use Ceased AU754212B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19820599 1998-05-08
DE19820599A DE19820599A1 (de) 1998-05-08 1998-05-08 Epothilonderivate, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP1999/003159 WO1999058534A2 (de) 1998-05-08 1999-05-07 Epithilonderivate, verfahren zu deren herstellung und deren verwendung

Publications (2)

Publication Number Publication Date
AU4361199A AU4361199A (en) 1999-11-29
AU754212B2 true AU754212B2 (en) 2002-11-07

Family

ID=7867085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43611/99A Ceased AU754212B2 (en) 1998-05-08 1999-05-07 Epothilone derivatives, a method for the production thereof, and their use

Country Status (14)

Country Link
US (2) US6982280B1 (https=)
EP (1) EP1077980B1 (https=)
JP (1) JP2002514649A (https=)
KR (1) KR20010052325A (https=)
AR (1) AR018344A1 (https=)
AT (1) ATE234842T1 (https=)
AU (1) AU754212B2 (https=)
CA (1) CA2330812A1 (https=)
DE (2) DE19820599A1 (https=)
ES (1) ES2195577T3 (https=)
HU (1) HUP0102283A3 (https=)
IL (1) IL139480A0 (https=)
TW (1) TW568910B (https=)
WO (1) WO1999058534A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO1999001124A1 (en) 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
GB9810659D0 (en) 1998-05-18 1998-07-15 Ciba Geigy Ag Organic compounds
US6518421B1 (en) 2000-03-20 2003-02-11 Bristol-Myers Squibb Company Process for the preparation of epothilone analogs
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
DE10355223A1 (de) * 2003-11-26 2005-06-30 Institut für Pflanzenbiochemie (IPB) Neue Makrocyclen zur Behandlung von Krebserkrankungen
EP1674098A1 (en) 2004-12-23 2006-06-28 Schering Aktiengesellschaft Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
US20110104664A1 (en) 2006-03-31 2011-05-05 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to micortubule-stabilizing agents
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
EP2065054A1 (en) 2007-11-29 2009-06-03 Bayer Schering Pharma Aktiengesellschaft Combinations comprising a prostaglandin and uses thereof
DE102007059752A1 (de) 2007-12-10 2009-06-18 Bayer Schering Pharma Aktiengesellschaft Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone
EP2070521A1 (en) 2007-12-10 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Surface-modified nanoparticles
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
EP2210584A1 (en) 2009-01-27 2010-07-28 Bayer Schering Pharma Aktiengesellschaft Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer
AU2011255647A1 (en) 2010-05-18 2012-11-15 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
US9764038B2 (en) 2011-12-23 2017-09-19 Innate Pharma Enzymatic conjugation of antibodies
WO2014009426A2 (en) 2012-07-13 2014-01-16 Innate Pharma Screening of conjugated antibodies
US10036010B2 (en) 2012-11-09 2018-07-31 Innate Pharma Recognition tags for TGase-mediated conjugation
EP2968582B1 (en) 2013-03-15 2020-07-01 Innate Pharma Solid phase tgase-mediated conjugation of antibodies
EP3010547B1 (en) 2013-06-20 2021-04-21 Innate Pharma Enzymatic conjugation of polypeptides
JP6744212B2 (ja) 2013-06-21 2020-08-19 イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． ポリペプチドの酵素的結合
WO2019092148A1 (en) 2017-11-10 2019-05-16 Innate Pharma Antibodies with functionalized glutamine residues

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010121A1 (de) * 1991-11-19 1993-05-27 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Epothilone, deren herstellungsverfahren und ihre verwendung als arzneimittel und pflanzenschützende mittel
DE19542986A1 (de) * 1995-11-17 1997-05-22 Biotechnolog Forschung Gmbh Epothilon-Derivate und deren Verwendung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5351146A (en) * 1993-03-01 1994-09-27 At&T Bell Laboratories All-optical network architecture
US5781537A (en) * 1995-07-07 1998-07-14 International Business Machines Corporation Setting up, taking down and maintaining connections in a communications network
DK1186606T4 (da) 1995-11-17 2011-12-05 Biotechnolog Forschung Gmbh Epothilonderivater, deres fremstilling og anvendelse
DK1367057T3 (da) 1996-11-18 2009-01-19 Biotechnolog Forschung Gmbh Epothiloner E og F
US6380394B1 (en) 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
US6304349B1 (en) * 1998-06-30 2001-10-16 Lucent Technologies Inc. WDM optical communications networks and methods for provisioning
US6445844B1 (en) * 1999-09-15 2002-09-03 Xros, Inc. Flexible, modular, compact fiber optic switch
US7092633B2 (en) * 2000-11-14 2006-08-15 University Of Texas System Board Of Regents System and method for configuring optical circuits
US6982951B2 (en) * 2000-12-21 2006-01-03 At&T Corp. Method for selecting a restoration path in a mesh network
US7212495B2 (en) * 2001-02-21 2007-05-01 Polytechnic University Signaling for reserving a communications path
AU2002305113A1 (en) * 2001-03-29 2002-10-15 Atoga Systems, Inc. Open ring architectures for optical wdm networks
US20020194339A1 (en) * 2001-05-16 2002-12-19 Lin Philip J. Method and apparatus for allocating working and protection bandwidth in a telecommunications mesh network
AU2002351589A1 (en) * 2001-06-27 2003-03-03 Brilliant Optical Networks Distributed information management schemes for dynamic allocation and de-allocation of bandwidth

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010121A1 (de) * 1991-11-19 1993-05-27 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Epothilone, deren herstellungsverfahren und ihre verwendung als arzneimittel und pflanzenschützende mittel
DE19542986A1 (de) * 1995-11-17 1997-05-22 Biotechnolog Forschung Gmbh Epothilon-Derivate und deren Verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICOLAOU K.C. ETAL,ANGEWANDTE CHEMIE,INT.ED.,98,37(1/2)84-87 *

Also Published As

Publication number Publication date
EP1077980B1 (de) 2003-03-19
EP1077980A2 (de) 2001-02-28
US20040259922A1 (en) 2004-12-23
KR20010052325A (ko) 2001-06-25
CA2330812A1 (en) 1999-11-18
ATE234842T1 (de) 2003-04-15
US6982280B1 (en) 2006-01-03
IL139480A0 (en) 2001-11-25
WO1999058534A3 (de) 2000-01-13
DE59904632D1 (de) 2003-04-24
HUP0102283A2 (hu) 2001-10-28
TW568910B (en) 2004-01-01
AR018344A1 (es) 2001-11-14
DE19820599A1 (de) 1999-11-11
WO1999058534A2 (de) 1999-11-18
JP2002514649A (ja) 2002-05-21
ES2195577T3 (es) 2003-12-01
HUP0102283A3 (en) 2002-03-28
AU4361199A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
AU754212B2 (en) Epothilone derivatives, a method for the production thereof, and their use
Dangroo et al. An efficient synthesis of phosphoramidates from halides in aqueous ethanol
KR20060119979A (ko) 쿠쿠르비트우릴의 제조 방법
AU2007261596A1 (en) Improved oxidation process with enhanced safety useful in the manufacture of moxidectin by means of stabilised 2-iodoxybenzoic acid (SIBX)
EP2420504B1 (en) Method for producing tetrahydropyran compound and intermediate thereof
JPH085866B2 (ja) 新規なアコニチン系化合物および鎮痛・抗炎症剤
KR20030017473A (ko) 항균 퀴놀론 약제용 중간물질로서의 알킬3-시클로프로필아미노-2-[2,4-디브로모-3-(디플루오로메톡시)벤조일]-2-프로페노에이트의 원-폿 합성방법
EP0119091B1 (en) 2,2-diethoxypropionic acid derivatives
KR970042580A (ko) 에토포시드의 제조방법
CA2508341A1 (en) Processes for preparing quinolonecarboxylate derivatives
KR0145402B1 (ko) (+)실릴옥시아크릴레이트 유도체 및 그 제조방법
Okada et al. A Simple and Efficient Synthetic Method for Fluorine-containing 7H-(1) Benzothiopyrano (3, 2-h)-quinolines
KR100449310B1 (ko) 2-데옥시-ｌ-리보스의 제조방법
CA2649506A1 (en) 2-alkenyl-3-aminothiophene derivative and process for producing thereof
IL112103A (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
CA1271483A (en) Method for brevicomin synthesis and use in beetle control
DE60315510T2 (de) Neue chirale hexansäureesterderivate, verfahren und zwischenprodukte zu deren herstellung sowie deren verwendung zur herstellung von chiraler 2-(brommethyl)-2-ethyl-hexansäure
MXPA00010953A (en) Epothilone derivatives, a method for the production thereof, and their use
KR0129601B1 (ko) 신규 제초성 트리아졸 유도체
Alvarez-Mendez et al. Modular total syntheses of thymifodioic/incanic acids
Desai et al. Phosphorus–nitrogen compounds. Part XXXI. Reactions of hexachlorocyclotriphosphazatriene with aniline
JPS5547673A (en) Novel pyrone derivative
JPS63198673A (ja) フルフリルアルコ−ル誘導体の製造法
JPS5690032A (en) Novel preparation of symmetric aromatic ketone
CA2209102A1 (en) Production method of optically active trans-vinylsulfide alcohol

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)